Richard J Benjamin insider trades: Cerus (CERS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | CERS | ↓ Sell10b5-1 | 101,740 | $1.66 | $169K | Direct | Mar 16, 2026 (4d) |
| Mar 9, 2026 | CERS | ↓ Sell | 125,894 | $1.99 | $251K | Direct | Mar 9, 2026 (0d) |
| Mar 14, 2025 | CERS | ↓ Sell | 49,024 | $1.45 | $71K | Direct | Mar 17, 2025 (3d) |
| Mar 7, 2025 | CERS | ↓ Sell | 26,139 | $1.50 | $39K | Direct | Mar 10, 2025 (3d) |
| Mar 4, 2025 | CERS | ↓ Sell10b5-1 | 57,546 | $1.57 | $91K | Direct | Mar 5, 2025 (1d) |
| Aug 2, 2024 | CERS | ↓ Sell10b5-1 | 21,605 | $2.50 | $54K | Direct | Aug 7, 2024 (5d) |
| Mar 14, 2024 | CERS | ↓ Sell10b5-1 | 35,115 | $2.02 | $71K | Direct | Mar 14, 2024 (0d) |
| Mar 8, 2024 | CERS | ↓ Sell10b5-1 | 29,378 | $2.40 | $70K | Direct | Mar 12, 2024 (4d) |
| Mar 13, 2023 | CERS | ↓ Sell10b5-1 | 25,353 | $2.79 | $71K | Direct | Mar 14, 2023 (1d) |
| Aug 9, 2022 | CERS | ↓ Sell10b5-1 | 10,000 | $5.12 | $51K | Direct | Aug 11, 2022 (2d) |
| Mar 14, 2022 | CERS | ↓ Sell10b5-1 | 30,307 | $5.04 | $153K | Direct | Mar 15, 2022 (1d) |
| Nov 3, 2021 | CERS | ↓ Sell10b5-1 | 165,000 | $7.68 | $1.3M | Direct | Nov 5, 2021 (2d) |
| Mar 15, 2021 | CERS | ↓ Sell10b5-1 | 49,331 | $6.36 | $314K | Direct | Mar 16, 2021 (1d) |
| Aug 24, 2020 | CERS | ↓ Sell10b5-1 | 100,000 | $7.90 | $790K | Direct | Aug 26, 2020 (2d) |
| Jul 7, 2020 | CERS | ↓ Sell10b5-1 | 154,583 | $7.20 | $1.1M | Direct | Jul 9, 2020 (2d) |
| Mar 17, 2020 | CERS | ↓ Sell10b5-1 | 26,570 | $3.59 | $96K | Direct | Mar 24, 2020 (7d) |
| Aug 7, 2019 | CERS | ↓ Sell | 16,444 | $5.01 | $82K | Direct | Aug 9, 2019 (2d) |
| Mar 13, 2019 | CERS | ↓ Sell | 9,890 | $5.96 | $59K | Direct | Mar 13, 2019 (0d) |
| Aug 28, 2018 | CERS | ↓ Sell | 50,000 | $7.52 | $376K | Direct | Aug 30, 2018 (2d) |
| May 11, 2018 | CERS | ↓ Sell | 8,631 | $6.69 | $58K | Direct | May 14, 2018 (3d) |
| Mar 13, 2018 | CERS | ↓ Sell | 3,680 | $4.98 | $18K | Direct | Mar 13, 2018 (0d) |
| Mar 14, 2017 | CERS | ↓ Sell | 1,189 | $4.15 | $5K | Direct | Mar 15, 2017 (1d) |
| Aug 14, 2014 | CERS | ↓ Sell | 35,416 | $7.20 | $255K | Direct | Aug 16, 2018 (1463d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CERS insiders
Open-market trades in the last 12 months
About Richard J Benjamin's insider trades
Richard J Benjamin is Chief Medical Officer at Cerus (CERS). Since Aug 14, 2014, Richard has reported no open-market purchases and 23 sales worth $5.5M on SEC Form 4. In the last 12 months: 2 sales ($420K).
13 sales (78% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CERS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.